CUTIVATE

This brand name is authorized in Cyprus, Ecuador, Estonia, Hong Kong, Lithuania, Malta, Mexico, Netherlands, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug CUTIVATE contains one active pharmaceutical ingredient (API):

1 Fluticasone
UNII O2GMZ0LF5W - FLUTICASONE PROPIONATE

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.

Read about Fluticasone

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CUTIVATE Lotion FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
D07AC17 Fluticasone D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07A Corticosteroids, plain → D07AC Corticosteroids, potent (group III)
Discover more medicines within D07AC17

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 24.370-1-01-12
Country: EE Ravimiamet Identifier(s): 1004847, 1006344, 1062087, 1062098
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 158443
Country: HK Department of Health Drug Office Identifier(s): 37755
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1000528, 1000530, 1022726, 1022727, 1079991, 1079992, 1081957, 1081958, 1084826, 1084875, 1085199, 1085794, 1087810, 1087811
Country: MT Medicines Authority Identifier(s): MA192/03801
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 210M97
Country: NL Z-Index G-Standaard Identifier(s): 13803735
Country: NL Z-Index G-Standaard, PRK Identifier(s): 38626, 38628, 38636
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100016334, 100016340
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65211001, W65212001
Country: SG Health Sciences Authority Identifier(s): 08628P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699522385041
Country: US FDA, National Drug Code Identifier(s): 10337-333, 10337-434
Country: ZA Health Products Regulatory Authority Identifier(s): 27/13.4.1/0441, 27/13.4.1/0442

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.